Global Healthcare Analyst

Tina Banerjee

Equity research analyst having 15+ years of experience, with an interest on fundamentally strong global healthcare companies. I have been helping investors to find future winners in healthcare space to grow their wealth by focusing on the strength and potential of the business models of the companies. My initiating coverage reports and pitch help investors to know ‘what to buy’, ‘why to buy’, and ‘when to buy’. My clients always remain on top of the sector with the help of my timely and detailed notes on earnings or any news update. I also provide broader view on the entire healthcare sector through periodic thematic reports.

Equity Capital Markets

Shenzhen Creality 3d Technology Co. Ltd. / Equity Capital Markets

Shenzhen Creality 3d Technology Co. Ltd. (2598001D HK)

<ul>
<li>Creality 3D Technology launched Hongkong IPO aiming to raise up to HK$1.4B (~ US$ 176M). They are a global consumer 3D printing product and service provider.</li>
<li>Creality 3D Technology intends to use the IPO proceeds to support R&amp;D, strengthen overseas operation, strategic investment &amp; acquisition and working capital.</li>
<li>The near to medium term challenge for the company is optimizing the costs and strengthen margins. In the near-term horizon, it looks expensive. Investors can pass for now.</li>
</ul>


Creality 3D Technology launched Hongkong IPO aiming to raise up to HK$1.4B (~ US$ 176M). They are a global consumer 3D printing product and service provider.
Creality 3D Technology intends to use the IPO proceeds to support R&amp;D, strengthen overseas operation, strategic investment &amp; acquisition and working capital.
The near to medium term challenge for the company is optimizing the costs and strengthen margins. In the near-term horizon, it looks expensive. Investors can pass for now.


Creality 3D Technology IPO: Not Yet Prospective On All Dimensions, Leaving Its Imprint On Few Though